» Articles » PMID: 11112341

Type IV Collagen Induces Matrix Metalloproteinase 2 Activation in HT1080 Fibrosarcoma Cells

Overview
Journal Exp Cell Res
Specialty Cell Biology
Date 2000 Dec 9
PMID 11112341
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Matrix metalloproteinase 2 (MMP-2) activation has been described as a "master switch" which triggers tumor spread and metastatic progression. We show here that type IV collagen, a major component of basement membranes, promotes MMP-2 activation by HT1080 cells. When plated on plastic, HT1080 cells constitutively processed the 66-kDa pro-MMP-2 into a 62-kDa intermediate activated form, most probably through a membrane type (MT) 1 MMP-dependent mechanism. In the presence of type IV collagen, part of this intermediate form was further processed to fully activated 59-kDa MMP-2. This activation was prevented by tissue inhibitor of MMP (TIMP)-2 and a broad-spectrum hydroxamic acid-based synthetic MMP inhibitor (GI129471). Type IV collagen-mediated pro-MMP-2 activation did not involve either a transcriptional modulation of MMP-2, MT1-MMP, or TIMP-2 expression nor any alteration of MT1-MMP protein synthesis or processing. An inverse relationship between MMP-2 activation and the concentration of secreted TIMP-2 was observed. This is consistent with our previous report that TIMP-2 degradation is probably linked to the MT1-MMP-dependent MMP-2 activation mechanism. Because invasive tumor cells must breach basement membranes at different steps of the metastatic dissemination, the ability of HT1080 cells to activate pro-MMP-2 in the presence of type IV collagen might represent a key regulatory mechanism for the acquisition of an invasive potential.

Citing Articles

Unravelling the distinct biological functions and potential therapeutic applications of TIMP2 in cancer.

Peeney D, Liu Y, Lazaroff C, Gurung S, Stetler-Stevenson W Carcinogenesis. 2022; 43(5):405-418.

PMID: 35436325 PMC: 9167030. DOI: 10.1093/carcin/bgac037.


Can VEGFC Form Turing Patterns in the Zebrafish Embryo?.

Wertheim K, Roose T Bull Math Biol. 2019; 81(4):1201-1237.

PMID: 30607882 PMC: 6397306. DOI: 10.1007/s11538-018-00560-2.


Conformation-dependent binding of a Tetrastatin peptide to αβ integrin decreases melanoma progression through FAK/PIK/Akt pathway inhibition.

Lambert E, Fuselier E, Ramont L, Brassart B, Dukic S, Oudart J Sci Rep. 2018; 8(1):9837.

PMID: 29959360 PMC: 6026150. DOI: 10.1038/s41598-018-28003-x.


Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells.

Cepeda M, Pelling J, Evered C, Williams K, Freedman Z, Stan I Mol Cancer. 2016; 15(1):65.

PMID: 27756325 PMC: 5070195. DOI: 10.1186/s12943-016-0547-x.


Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion.

Hammer A, Diakonova M Adv Exp Med Biol. 2014; 846:97-137.

PMID: 25472536 PMC: 4576997. DOI: 10.1007/978-3-319-12114-7_5.